Breast cancer screening is one of the topics the report focusses on.
Breast cancer screening is one of the topics the report focusses on.

Source: Nevit Dilmen, 40F MLO DMMG, CC BY-SA 3.0

Insight report

More screening and secondary prevention needed

For World Patient Safety Day, Health First Europe (HFE) published a comprehensive insight report on five disease areas that affect millions of European citizens each year and how the European Union could and should do a better job for its citizens.

HFE is a non-profit, non-commercial alliance of patients, healthcare workers, academics, healthcare experts and the medical technology industry. The report focuses on breast cancer, type 2 Diabetes, healthcare-associated infections (HAIs), heart failure and severe combined immune deficiencies (SCID). It outlines the burden of such diseases to the healthcare systems of the European Union and shows the solutions and concrete examples known to be effective in screening programmes for these diseases. It also lays out concrete policy recommendations to improve outcomes for patients and society throughout the EU.

Photo
Source: HFE

“This insight report is potentially game-changing as it shows how much screening and secondary prevention can help to improve our healthcare systems,” said Roberto Bertollini, Honorary President of Health First Europe, and a former Chief Scientist of the WHO Regional Office for Europe. “If this report doesn’t demonstrate the importance of boosting the availability of screening programmes in Europe, I am not sure what will.”  

For breast cancer screening, the editors of the report recommend promoting appropriate health information systems linked to screening programmes and existing cancer and mortality registries. Furthermore, primary and secondary preventive strategies should be integrated through comprehensive approaches to support the implementation of best practices and to minimise the current inequalities in breast cancer control.

Photo
Source: HFE

For the treatment of cardiovascular diseases, the experts said that it must be ensured that patients have timely access to diagnostic services and treatment of heart failure, through appropriate reimbursement procedures in all relevant settings.

HFE Executive Director Brandon Mitchener said that the current impact of the analysed diseases on EU healthcare systems highlights the need to boost secondary prevention and screening programmes across the EU. “The use of digital tools in particular has the potential to unlock a pool of valuable knowledge in an unprecedented way to prevent diseases and identify early signals of poor health,” he said. 

The report highlights that screening programmes and systematic health checks for noncommunicable diseases are still not routine in most European countries.

John Bowis, HFE Co-Patron and a former Member of the European Parliament, said that the report is “a clear warning to policymakers that the role of secondary prevention and screening needs to be taken much more seriously. These are key enablers for saving lives while ensuring the sustainability of our healthcare systems.” (SB)

17.09.2021

Read all latest stories

Related articles

Photo

Mammography

Benefits: Are they a question of beliefs?

A panel of experts has recommended that existing programmes be phased out and that systematic screening programmes be replaced with systematic screening information that would give women the…

Photo

Additional costs that pay off

For women with dense breasts, MRIs are cost effective for detecting breast cancer

New research indicates that MRIs are cost effective for detecting breast cancer for women with very dense breasts detected by mammography. About 10% of women have extremely dense breasts, and current…

Photo

Breast cancer backlog

Getting cancer screening programmes back on track with AI and digitisation

The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been…

Related products

Therapixel · MammoScreen

Artificial Intelligence

Therapixel · MammoScreen

Therapixel
Analyticon Biotechnologies AG - Urilyzer 100 Pro

Urinalysis

Analyticon Biotechnologies AG - Urilyzer 100 Pro

Analyticon Biotechnologies AG
Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Greiner – VACUETTE FC Mix tube

Blood Glucose

Greiner – VACUETTE FC Mix tube

Greiner Bio-One
Hologic - I-View 2.0 Contrast Enhanced Imaging

Mammo Workstations

Hologic - I-View 2.0 Contrast Enhanced Imaging

Hologic, Inc.
Hologic - LOCalizer wire-free guidance system

Accessories / Complementary Systems

Hologic - LOCalizer wire-free guidance system

Hologic, Inc.
Subscribe to Newsletter